Generic drugs Vs brand: Here's how experts are looking at it

Pharma stocks are in focus as the health ministry has asked doctors to prescribe generic names of drugs versus branded names.

In an interview to CNBC-TV18, Kewal Handa, Industry Expert & Former MD of Pfizer shared his readings on how will this change the dynamics of the industry.

He said that Medical Council of India (MCI) guidelines have been there for a year.

Handa said that the challenge would be to prescribe fixed dose combination drugs. However, need to see if the industry has a mechanism of checks and balances, he said.